Data / Drug companies / Apotex Inc.
Apotex Inc.: 21 products in the FDA NDC directory, labeler code 49867
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Apotex Inc. (labeler code 49867) lists 21 products in the FDA National Drug Code Directory. By type: 21 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on July 28, 2022.
The request: Watch Apotex Inc. (FDA labeler code 49867): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 49867
- Products in commercial distribution
- 21
- Packages
- 21
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 17, 2008
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 21 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 21 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 21 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Olanzapine | 49867-0073 | Powder | Bulk ingredients | July 28, 2022 |
| Fluticasone propionate | 49867-0076 | Powder | Bulk ingredients | December 30, 2020 |
| Dabigatran etexilate mesylate | 49867-0075 | Powder | Bulk ingredients | July 3, 2020 |
| Mycophenolate sodium | 49867-0077 | Powder | Bulk ingredients | June 16, 2020 |
| Deferprone | 49867-0071 | Powder | Bulk ingredients | December 29, 2017 |
| Risedronate sodium hemipentahydrate | 49867-0068 | Powder | Bulk ingredients | December 29, 2017 |
| Ibandronate sodium | 49867-0066 | Powder | Bulk ingredients | December 29, 2017 |
| Atomoxetine hydrochloride | 49867-0065 | Powder | Bulk ingredients | December 29, 2017 |
| Alfuzosin hydrochloride | 49867-0049 | Powder | Bulk ingredients | December 29, 2017 |
| Aripiprazole | 49867-0047 | Powder | Bulk ingredients | December 29, 2017 |
| Ziprasidone hydrochloride | 49867-0044 | Powder | Bulk ingredients | December 29, 2017 |
| Midodrine hydrochloride | 49867-0029 | Powder | Bulk ingredients | December 29, 2017 |
| Paroxetine hydrochloride anhydrous | 49867-0023 | Powder | Bulk ingredients | December 29, 2017 |
| Tasimelteon | 49867-0080 | Powder | Bulk ingredients | July 31, 2017 |
| Paliperidone | 49867-0063 | Powder | Bulk ingredients | October 25, 2015 |
| Rivaroxaban | 49867-0079 | Powder | Bulk ingredients | December 14, 2014 |
| Adefovir dipivoxil | 49867-0074 | Powder | Bulk ingredients | December 7, 2012 |
| Memantine hydrochloride | 49867-0059 | Powder | Bulk ingredients | May 14, 2012 |
| Olanzapine | 49867-0056 | Powder | Bulk ingredients | November 24, 2010 |
| Atorvastatin calcium propylene glycol solvate | 49867-0054 | Powder | Bulk ingredients | April 26, 2010 |
| Olanzapine | 49867-0078 | Powder | Bulk ingredients | September 17, 2008 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.